338 related articles for article (PubMed ID: 33012873)
1. Asenapine Transdermal Patch for the Management of Schizophrenia.
Zhou M; Derakhshanian S; Rath A; Bertrand S; DeGraw C; Barlow R; Menard A; Kaye AM; Hasoon J; Cornett EM; Kaye AD; Viswanath O; Urits I
Psychopharmacol Bull; 2020 Sep; 50(4):60-82. PubMed ID: 33012873
[TBL] [Abstract][Full Text] [Related]
2. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.
Citrome L
Int J Clin Pract; 2009 Dec; 63(12):1762-84. PubMed ID: 19840150
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the clinical efficacy of asenapine in schizophrenia.
Minassian A; Young JW
Expert Opin Pharmacother; 2010 Aug; 11(12):2107-15. PubMed ID: 20642375
[TBL] [Abstract][Full Text] [Related]
4. In brief: An asenapine patch (Secuado) for schizophrenia.
Med Lett Drugs Ther; 2021 Jan; 63(1615):7-8. PubMed ID: 33647000
[No Abstract] [Full Text] [Related]
5. Asenapine versus placebo for schizophrenia.
Hay A; Byers A; Sereno M; Basra MK; Dutta S
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011458. PubMed ID: 26599405
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic Profile of the Asenapine Transdermal System (HP-3070).
Suzuki K; Castelli M; Komaroff M; Starling B; Terahara T; Citrome L
J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):286-294. PubMed ID: 33734167
[TBL] [Abstract][Full Text] [Related]
7. Asenapine: a synthesis of efficacy data in bipolar mania and schizophrenia.
McIntyre RS; Wong R
Clin Schizophr Relat Psychoses; 2012 Jan; 5(4):217-20. PubMed ID: 22182459
[TBL] [Abstract][Full Text] [Related]
8. Asenapine: a clinical review of a second-generation antipsychotic.
Stoner SC; Pace HA
Clin Ther; 2012 May; 34(5):1023-40. PubMed ID: 22494521
[TBL] [Abstract][Full Text] [Related]
9. Transdermal Asenapine in Schizophrenia: A Systematic Review.
Carrithers B; El-Mallakh RS
Patient Prefer Adherence; 2020; 14():1541-1551. PubMed ID: 32943849
[TBL] [Abstract][Full Text] [Related]
10. Asenapine Treatment in Pediatric Patients with Bipolar I Disorder or Schizophrenia: A Review.
Stepanova E; Grant B; Findling RL
Paediatr Drugs; 2018 Apr; 20(2):121-134. PubMed ID: 29170943
[TBL] [Abstract][Full Text] [Related]
11. Asenapine: a new antipsychotic option.
Henry JM; Fuller MA
J Pharm Pract; 2011 Oct; 24(5):447-51. PubMed ID: 22156709
[TBL] [Abstract][Full Text] [Related]
12. Development and Optimization of Asenapine Sublingual Film Using QbD Approach.
Dalal R; Shah J; Gorain B; Choudhury H; Jacob S; Mehta TA; Shah H; Nair AB
AAPS PharmSciTech; 2021 Oct; 22(7):244. PubMed ID: 34608546
[TBL] [Abstract][Full Text] [Related]
13. Asenapine: an atypical antipsychotic with atypical formulations.
Musselman M; Faden J; Citrome L
Ther Adv Psychopharmacol; 2021; 11():20451253211035269. PubMed ID: 34540197
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of HP-3070, an Asenapine Transdermal System, in Patients With Schizophrenia: A Phase 3, Randomized, Placebo-Controlled Study.
Citrome L; Walling DP; Zeni CM; Starling BR; Terahara T; Kuriki M; Park AS; Komaroff M
J Clin Psychiatry; 2020 Dec; 82(1):. PubMed ID: 33326711
[TBL] [Abstract][Full Text] [Related]
15. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU
CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950
[TBL] [Abstract][Full Text] [Related]
16. Asenapine: a clinical overview.
Potkin SG
J Clin Psychiatry; 2011; 72 Suppl 1():14-8. PubMed ID: 22217438
[TBL] [Abstract][Full Text] [Related]
17. Asenapine: Pharmacological Aspects and Role in Psychiatric Disorders.
Reyad AA; Mishriky R
Psychiatr Danub; 2019 Jun; 31(2):157-161. PubMed ID: 31291219
[TBL] [Abstract][Full Text] [Related]
18. Asenapine pharmacokinetics and tolerability in a pediatric population.
Dogterom P; Riesenberg R; de Greef R; Dennie J; Johnson M; Pilla Reddy V; Miltenburg AM; Findling RL; Jakate A; Carrothers TJ; Troyer MD
Drug Des Devel Ther; 2018; 12():2677-2693. PubMed ID: 30214156
[TBL] [Abstract][Full Text] [Related]
19. Asenapine: a review of acute and extension phase data in bipolar disorder.
McIntyre RS
CNS Neurosci Ther; 2011 Dec; 17(6):645-8. PubMed ID: 20950326
[TBL] [Abstract][Full Text] [Related]
20. Design of long acting invasomal nanovesicles for improved transdermal permeation and bioavailability of asenapine maleate for the chronic treatment of schizophrenia.
El-Tokhy FS; Abdel-Mottaleb MMA; El-Ghany EA; Geneidi AS
Int J Pharm; 2021 Oct; 608():121080. PubMed ID: 34506923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
